|
SNAP29 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.559790E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.109000E-01 |
| Normal-vs-Stage2 |
1.569180E-01 |
| Normal-vs-Stage3 |
6.336300E-03 |
| Normal-vs-Stage4 |
3.106100E-02 |
| Stage1-vs-Stage2 |
6.873500E-02 |
| Stage1-vs-Stage3 |
5.956000E-04 |
| Stage1-vs-Stage4 |
7.377100E-03 |
| Stage2-vs-Stage3 |
5.001400E-01 |
| Stage2-vs-Stage4 |
6.948200E-01 |
| Stage3-vs-Stage4 |
7.678400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.080000E-01 |
| Normal-vs-AfricanAmerican |
9.708300E-02 |
| Normal-vs-Asian |
5.246800E-01 |
| Caucasian-vs-AfricanAmerican |
3.295400E-01 |
| Caucasian-vs-Asian |
8.985600E-01 |
| AfricanAmerican-vs-Asian |
7.972000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.876100E-02 |
| Normal-vs-Female |
9.960200E-01 |
| Male-vs-Female |
2.631500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.737500E-03 |
| Normal-vs-Age(41-60Yrs) |
5.583000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.170790E-01 |
| Normal-vs-Age(81-100Yrs) |
6.083000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.429800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.054230E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.105200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.733200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.999200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.705400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.303720E-03 |
| Normal-vs-Grade 2 |
9.713400E-01 |
| Normal-vs-Grade 3 |
9.811800E-02 |
| Normal-vs-Grade 4 |
1.579720E-04 |
| Grade 1-vs-Grade 2 |
9.499300E-03 |
| Grade 1-vs-Grade 3 |
2.357900E-03 |
| Grade 1-vs-Grade 4 |
4.3709999999475E-06 |
| Grade 2-vs-Grade 3 |
5.567600E-02 |
| Grade 2-vs-Grade 4 |
6.40549999999518E-05 |
| Grade 3-vs-Grade 4 |
1.760100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.099900E-02 |
| Normal-vs-ccB subtype |
8.22420000000657E-05 |
| ccA subtype-vs-ccB subtype |
5.3902438068576E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.339590E-01 |
| Normal-vs-N1 |
3.684200E-01 |
| N0-vs-N1 |
6.205600E-01 |
|
|
